Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease

https://doi.org/10.20996/1819-6446-2021-02-11

Full Text:

Abstract

Aim. To compare clinical features, drug therapy and outcomes in patients with non-obstructive and obstructive coronary artery infarction.

Material and methods. The study included 206 patients with a diagnosis of myocardial infraction (MI). According to the results of coronarography, patients were divided into two groups: 103 patients (group 1; MINOCA) did not have obstructive involvement coronary arterial (CA): in 67 (65%) of cases, there is no data for atherosclerotic coronary bed lesion, another 36 (35%) – have CA stenosis up to 50%. 103 patients (group 2) with MI and obstructive CA (MIOCA). The patients of the second group in 100% of cases underwent endoprosthesis of CA, the affection of which caused infraction. The second group was selected by the copy method comparatively to the first group. The analysis of clinical peculiarities, medication and outcomes was made in these groups of patients, in particular.

Results and conclusions. The clinical “portrait” of patients with MI in nonobstructive and obstructive CA involvement did not differ significantly. Higher serum level of total cholesterol (5.6 [4.4;6.2] vs 5.1 [4.4;5.8] mmol/l р=0.04) and cholesterol of low-density lipoproteins (2.9 [2.2;3.5] vs 2.5 [2.1;2.9] mmol/l р=0,01), troponin [2.8 [0.7;15.0] vs 1.2 [0.1;7.7] ng/ml р=0.02) were identified in blood tests of MIOCA patients in the comparison with MINOCA group. Antero-lateral (р=0.02) and unspecified localization of MI (р=0.03) was more frequent in the MINOCA group. The differences in therapeutic approach were manifested in the more frequent prescription of double antiplatelet therapy: (99.0% vs 80.6% р< 0.01) in MIOCA patients. In the MINOCA group а more frequent prescription of dihydropyridine calcium channel blocking agents was registered (23.3% vs 2.9% р<0.01). The unfavorable outcomes for MINOCA is comparable to MIOCA in terms of the incidence of hospital mortality (2.9% against 4.9%; p>0.05), annual mortality (5.1% against 7.8%; p>0.05), and combined endpoint (6.8% against 10.7%; p>0.05).

Conclusion. Despite the similarity of the clinical presentations of MI with obstructive and nonobstructive CA involvement in real clinical practice, there are differences in the pharmacotherapeutic approach in the management of these groups of patients. MINOCA is characterized by an unfavorable outcomes similar to MIOCA.

About the Authors

O. A. Fomina
Ryazan Regional Clinical Cardiology Dispensary
Russian Federation

Olga A. Fomina

Ryazan



S. S. Yakushin
Ryazan State Medical University n.a. academician I.P. Pavlov
Russian Federation

Sergey S. Yakushin

Ryazan

eLibrary SPIN: 7726-7198



References

1. Ibanez B., James S., Agewall S., Antunes M.J., et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. DOI:10.1093/eurheartj/ehx393.

2. Yakushin S.S. Myocardial Infarction with Nonobstructive Coronary Arteries (МINОСА) - a Trendy Term or a New Diagnostic Concept? Rational Pharmacotherapy in Cardiology. 2018;14(5):765-73 (In Russ.) DOI:10.20996/1819-6446-2018.

3. Pasupathy S., Air T., Dreyer R.P., et al. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131(10):861-70. DOI:10.1161/CIRCULATIONAHA.114.011201.

4. Dyatlov N.V., Lykov Yu.V., Zhelnov V.V., Dvoretsky L.I. Some features of the pathogenesis of acute myocardial infarction with non-obstructive damage to the coronary arteries. Meditsinskiy vestnik Severnogo Kavkaza. 2017;12(3):260-5 (In Russ.) DOI:10.14300/mnnc.2017.12078.

5. Ryabov V.V., Syrkina A.G., Belokopytova N.V., et al. Acute coronary syndrome with elevation of the ST segment in patients with nonobstructive coronary lesion: data from the RECORD-3 register. Russian Journal of Cardiology. 2017;11(151):15-21 (In Russ.) DOI:10.15829/1560-4071-2017-11-15-21.

6. Kosmacheva E.D., Kruchinova S.V., Raff S.A., Porkhanov V.A. Myocardial infarction without obstructive changes in the coronary arteries: data from the total register of ACS in the Krasnodar Territory. Neotlozhnaya Kardiologiya. 2016;4:3-10 (In Russ.)

7. Nathaniel R.S., Asha M.M., Matthew T.R., et al. Mortality of Myocardial Infarction by Sex, Age, and Obstructive Coronary Artery Disease Status in the ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With the Guidelines). Circulation: Cardiovascular Quality and Outcomes. 2017;10(12):e003443. DOI:10.1161/CIRCOUTCOMES.116.003443.

8. Bainey K., Welsh R., Alemayehu W., et al. Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. International Journal of Cardiology. 2018;264:12-7. DOI: 10.1016/j.ijcard.2018.04.004.

9. Safdar B., Spatz E.S., Dreyer R.P., et al. Presentation, Clinical Profile, and Prognosis of Young Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: Results From the VIRGO Study. Journal of the American Heart Association. 2018;7(13):e009174. DOI:10.1161/JAHA.118.009174.

10. Collet J.P., Thiele H., Barbato E., et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2020;00:1-79. DOI:10.1093/eurheartj/ehaa575.

11. Lindahl B., Baron T., Erlinge D., et al. Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients with Myocardial Infarction with Non-Obstructive Coronary Artery Disease. Circulation. 2017;135(16):1481-9. DOI:10.1161/CIRCULATIONAHA.116.026336.

12. Thygesen K., Alpert J.S., Jaffe A.S., et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40(3):237-269. DOI:10.1093/eurheartj/ehy462.


For citation:


Fomina O.A., Yakushin S.S. Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease. Rational Pharmacotherapy in Cardiology. 2021;17(1):56-61. (In Russ.) https://doi.org/10.20996/1819-6446-2021-02-11

Views: 159


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)